Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.41 USD | +0.17% | +2.30% | -22.18% |
06-10 | C4 Therapeutics Appoints Ron Cooper Board Chairman | MT |
06-03 | CSG Systems International Acquires iCG Pay | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.18% | 1.18B | B | ||
-11.95% | 194B | A- | ||
+0.46% | 165B | B+ | ||
+5.45% | 158B | B- | ||
+6.44% | 101B | A- | ||
+49.08% | 92.63B | C- | ||
+15.76% | 84.68B | A- | ||
-0.66% | 75.94B | A | ||
-1.24% | 46.91B | A- | ||
-35.78% | 42.79B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CSGS Stock
- Ratings CSG Systems International, Inc.